Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-07-17
DOI
10.3389/fphar.2023.1199883
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes
- (2023) Maha K. Rahim et al. CELL
- LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis
- (2022) Fangjing Zhong et al. Journal of Cancer
- A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism‐related long noncoding RNAs
- (2022) Guo‐Jian Shi et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer
- (2022) Pingting Ye et al. Cancers
- Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics
- (2022) Elżbieta Wanowska et al. Frontiers in Cell and Developmental Biology
- Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer
- (2022) Liangping Zhang et al. Computational and Mathematical Methods in Medicine
- A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma
- (2022) Bo Chen et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
- (2022) Zi-Rong Jiang et al. Frontiers in Oncology
- Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
- (2022) Sahyun Pak et al. Frontiers in Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Long noncoding RNA TP53TG1 suppresses the growth and metastasis of hepatocellular carcinoma by regulating the PRDX4/β-catenin pathway
- (2021) Baiyang Chen et al. CANCER LETTERS
- Roles of BTLA in Immunity and Immune Disorders
- (2021) Zhaochen Ning et al. Frontiers in Immunology
- Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m6A methylation promotes disease progression and sorafenib resistance
- (2021) Yi-tian Chen et al. Human Cell
- LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability
- (2021) Peng-Ping Li et al. Aging-US
- Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma
- (2021) Yulu Wang et al. Biology-Basel
- TRIP13 regulates DNA repair pathway choice through REV7 conformational change
- (2020) Connor S. Clairmont et al. NATURE CELL BIOLOGY
- A UNIQUE CDK4/6 INHIBITOR: CURRENT AND FUTURE THERAPEUTIC STRATEGIES OF ABEMACICLIB
- (2020) Qing-Yun Chong et al. PHARMACOLOGICAL RESEARCH
- Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration
- (2020) Stéphanie Blockhuys et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
- (2020) Chunxiao Li et al. Molecular Cancer
- Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
- (2020) Yuqiong Xia et al. ADVANCED MATERIALS
- Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
- (2020) Florida Voli et al. CANCER RESEARCH
- PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
- (2020) Maddison Rose et al. Frontiers in Cell and Developmental Biology
- Serum copper and zinc levels in breast cancer: A meta-analysis
- (2020) Yue Feng et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Mechanisms of PARP inhibitor sensitivity and resistance
- (2018) Alan D. D’Andrea DNA REPAIR
- Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a
- (2018) Yun-xiao Zhou et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
- (2018) Zhiqiang Li et al. CANCER CELL
- Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
- (2018) Eylem Kulkoyluoglu-Cotul et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Roles of Copper-Binding Proteins in Breast Cancer
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PARPi focus the spotlight on replication fork protection in cancer
- (2017) Katharina Schlacher NATURE CELL BIOLOGY
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer
- (2016) Maria Teresa Herrera-Abreu et al. CANCER RESEARCH
- Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
- (2015) Jennifer L. Allensworth et al. Molecular Oncology
- Current and emerging biomarkers in breast cancer: prognosis and prediction
- (2010) Marion T Weigel et al. ENDOCRINE-RELATED CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started